Connection

PAUL KLOTMAN to Kidney Diseases

This is a "connection" page, showing publications PAUL KLOTMAN has written about Kidney Diseases.
Connection Strength

1.909
  1. Kidney disease in HIV infection: introduction. Semin Nephrol. 2008 Nov; 28(6):511-2.
    View in: PubMed
    Score: 0.215
  2. Efavirenz: innocent bystander or direct nephrotoxin? AIDS. 2007 Jun 19; 21(10):1393.
    View in: PubMed
    Score: 0.196
  3. Renal safety of tenofovir disoproxil fumarate. AIDS Read. 2007 Feb; 17(2):90-2, 99-104, C3.
    View in: PubMed
    Score: 0.191
  4. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006 Mar; 5(2):275-87.
    View in: PubMed
    Score: 0.179
  5. Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol. 2006 Apr; 17(4):996-1004.
    View in: PubMed
    Score: 0.179
  6. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002 May; 8(5):522-6.
    View in: PubMed
    Score: 0.137
  7. Gene therapy and renal disease. Introduction. Kidney Int. 2002 Jan; 61(1 Suppl):S1-2.
    View in: PubMed
    Score: 0.134
  8. Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J Am Soc Nephrol. 2001 Dec; 12(12):2645-2651.
    View in: PubMed
    Score: 0.133
  9. Molecular therapy for renal diseases. Am J Kidney Dis. 1996 Oct; 28(4):475-92.
    View in: PubMed
    Score: 0.093
  10. Transgenic animal models of renal development and pathogenesis. Am J Physiol. 1995 Nov; 269(5 Pt 2):F601-20.
    View in: PubMed
    Score: 0.087
  11. World Kidney Day 2011. J Am Soc Nephrol. 2011 Mar; 22(3):397-8.
    View in: PubMed
    Score: 0.063
  12. World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. J Am Soc Nephrol. 2009 Mar; 20(3):453-5.
    View in: PubMed
    Score: 0.055
  13. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 2009 Feb; 75(4):428-34.
    View in: PubMed
    Score: 0.054
  14. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A. 2004 Feb 24; 101(8):2488-93.
    View in: PubMed
    Score: 0.039
  15. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001 Jun 28; 344(26):1979-84.
    View in: PubMed
    Score: 0.032
  16. Adeno-associated virus gene transfer into renal cells: potential for in vivo gene delivery. Exp Nephrol. 1998 May-Jun; 6(3):189-94.
    View in: PubMed
    Score: 0.026
  17. Renal TGF-beta in HIV-associated kidney diseases. Kidney Int. 1997 May; 51(5):1568-77.
    View in: PubMed
    Score: 0.024
  18. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest. 1996 Jun; 74(6):991-1003.
    View in: PubMed
    Score: 0.023
  19. Transgenic models of human immunodeficiency virus type-1. Curr Top Microbiol Immunol. 1996; 206:197-222.
    View in: PubMed
    Score: 0.022
  20. Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase. J Am Soc Nephrol. 2013 Apr; 24(5):801-11.
    View in: PubMed
    Score: 0.018
  21. Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. J Am Soc Nephrol. 1999 Sep; 10(9):1908-15.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.